Soleno Therapeutics (SLNO) Enterprise Value (QoQ) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.33% |
| Dec 31, 2025 | 38.78% |
| Sep 30, 2025 | -73.94% |
| Jun 30, 2025 | 1.07% |
| Mar 31, 2025 | 0.52% |
| Dec 31, 2024 | -13.50% |
| Sep 30, 2024 | 3.52% |
| Jun 30, 2024 | -77.89% |
| Mar 31, 2024 | 11.83% |
| Dec 31, 2023 | -223.82% |
| Sep 30, 2023 | -170.55% |
| Jun 30, 2023 | -145.16% |
| Mar 31, 2023 | 45.90% |
| Dec 31, 2022 | 26.07% |
| Sep 30, 2022 | 17.93% |
| Jun 30, 2022 | 17.02% |
| Mar 31, 2022 | -36.12% |
| Dec 31, 2021 | 24.41% |
| Sep 30, 2021 | 16.11% |
| Jun 30, 2021 | 19.25% |
| Mar 31, 2021 | 15.47% |
| Dec 31, 2020 | 12.31% |
| Sep 30, 2020 | 10.18% |
| Jun 30, 2020 | -314.72% |
| Mar 31, 2020 | 27.31% |
| Dec 31, 2019 | -84.70% |
| Sep 30, 2019 | 27.59% |
| Jun 30, 2019 | 20.10% |
| Mar 31, 2019 | 16.01% |
| Dec 31, 2018 | -125.60% |
| Sep 30, 2018 | 18.69% |
| Jun 30, 2018 | 15.29% |
| Mar 31, 2018 | 13.06% |
| Dec 31, 2017 | -48,757.14% |
| Sep 30, 2017 | 0.00% |
| Jun 30, 2017 | 0.00% |
| Mar 31, 2017 | 98.72% |
| Dec 31, 2016 | 49.66% |
| Sep 30, 2016 | -116.43% |
| Jun 30, 2016 | 61.46% |
| Mar 31, 2016 | -18.15% |
| Dec 31, 2015 | -16.41% |
| Sep 30, 2015 | 37.32% |
| Jun 30, 2015 | 20.98% |
| Mar 31, 2015 | -19.76% |
| Dec 31, 2014 | -12,332.36% |
| Sep 30, 2014 | 94.70% |
| Jun 30, 2014 | -58.12% |
| Mar 31, 2014 | 39.78% |
| Dec 31, 2013 | 36.31% |